April 26, 2018
ASA: Anesthesia drug shortages affecting patient care
Editor's Note
The American Society of Anesthesiologists (ASA) on April 25 reported that a national drug shortage of injectable opioids and local anesthetics is negatively affecting care received by patients under anesthesia.
An informal survey of 2,500 ASA members, found that 98% are now experiencing drug shortages at their institutions, and more than 95% say the shortages are affecting the way they treat their patients.
The top five drugs in short supply are hydromorphone, fentanyl, morphine, bupivacaine, and epinephrine.
Free Daily News
- Anthem’s anesthesia time limit policy, reversal sparks new legislation
- Simple procedure or ‘surgery’? Questionable medical billing practices cause confusion
- Antitrust guideline withdrawal could dampen M&A, boost uncertainty for provider joint ventures
- Surgeons emphasize bariatric surgery benefits amid rising GLP-1 drug popularity
- Study: Geriatric surgery program improves outcomes, independence
- Milestone pig kidney transplant offers hope amid ethical, safety questions
- Fitch Ratings: Hospital credit outlook improves amid stabilizing margins
- Annual Leapfrog Group awards recognize top hospitals, ASCs
- US obesity rates decline for first time in a decade
- Study: Active monitoring without surgery safe for certain low-risk DCIS patients
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement